Related Topics

    Jeha: News Releases & Feature Stories

    Baby, Oh Baby - Camille Davis

    The tiniest patients face the biggest odds when it comes to acute lymphoblastic leukemia. St. Jude clinicians and researchers work to change that scenario.

    St. Jude Acute Lymphoblastic Leukemia Team recognized with prestigious science award

    Scientists at St. Jude Children’s Research Hospital who represent the interdisciplinary team studying acute lymphoblastic leukemia (ALL) have been recognized by the American Association for Cancer Research (AACR) with the AACR Team Science Award.

    Giving children access to clinical trials is crucial, Clofarabine approval shows

    Accelerated approval of the drug clofarabine to treat relapsed or refractory pediatric acute lymphoblastic leukemia (ALL) shows the importance of offering children rapid access to new treatments through clinical trials, said investigators at St. Jude.

    Drug offers hope to children with unresponsive or relapsed leukemia

    Data from a clinical trial led by investigators at St. Jude Children's Research Hospital with the investigational agent clofarabine were presented June 5 at the 40th annual meeting of the American Society of Clinical Oncology.